BLOOMBERG RADIO INTERVIEW

In a conversation with Tom Moroney and Peter Barnes that highlights the power of the protein, Quanterix CEO Kevin Hrusovsky explains how Simoa is powering advances in research, specifically for the detection and treatment of Alzheimer’s and other neurodegenerative diseases.